MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis

BACKGROUND: Dysregulation of the mesenchymal epithelial transition (MET) pathway contributes to poor clinical outcomes in patients with non-small cell lung cancer (NSCLC). Numerous clinical trials are currently investigating several therapies based on modulation of the MET pathway. OBJECTIVES: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Linrui, Wang, Faping, Luo, Fengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646943/
https://www.ncbi.nlm.nih.gov/pubmed/36387098
http://dx.doi.org/10.3389/fonc.2022.1013299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646943/
https://www.ncbi.nlm.nih.gov/pubmed/36387098
http://dx.doi.org/10.3389/fonc.2022.1013299

Ejemplares similares